Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Stallergenes Greer Showcases Developments in Respiratory and Food Allergy Care at EAACI 2025

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Health
General Health
Research
Pharmaceutical
Science
Biotechnology
EAACI

More Like This

Business Wire logo

Stallergenes Greer Showcases New Data for Food and Respiratory Immunotherapy at 2024 EAACI Congress

Stallergenes Greer Foundation Announces Winners of 2023 Science Awards for Allergy

Business Wire logo

Science Awards for Allergy 2025: Call for Applications

Business Wire logo

Stallergenes Greer Publishes in the Lancet Regional Health-Europe Landmark EfficAPSI Real-world Study Confirming Significant Benefit of Its Liquid Sublingual AIT on the Onset and Progression of Allergic Asthma

Andreas Amrein (Photo: Stallergenes Greer)

Stallergenes Greer Announces Appointment of Andreas Amrein as Chief Executive Officer

GlobeNewswire associated0

EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future

GlobeNewswire associated0

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

GlobeNewswire associated0

EAACI Congress Kicks Off in Valencia, Spain

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us